Home
>
National Drug Code (NDC)
>
CILOSTAZOL
CILOSTAZOL - 16590-285-30 - (CILOSTAZOL)
Drug Information of CILOSTAZOL
| Product NDC: | 16590-285 |
| Proprietary Name: | CILOSTAZOL |
| Non Proprietary Name: | CILOSTAZOL |
| Active Ingredient(s): | 100 mg/1 & nbsp; CILOSTAZOL |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CILOSTAZOL
| Product NDC: | 16590-285 |
| Labeler Name: | STAT RX USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077022 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060906 |
Package Information of CILOSTAZOL
| Package NDC: | 16590-285-30 |
| Package Description: | 30 TABLET in 1 BOTTLE (16590-285-30) |
NDC Information of CILOSTAZOL
| NDC Code | 16590-285-30 |
| Proprietary Name | CILOSTAZOL |
| Package Description | 30 TABLET in 1 BOTTLE (16590-285-30) |
| Product NDC | 16590-285 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CILOSTAZOL |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20060906 |
| Marketing Category Name | ANDA |
| Labeler Name | STAT RX USA LLC |
| Substance Name | CILOSTAZOL |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
